Appendix Table 2 Patient characteristics according to infection status in four point-prevalence studies 2013–2016
| Â | Overall | With any type of HAI | With one of the four included HAI types (study population) |
|---|---|---|---|
N | 2972 | 249 | 116 |
Median age in years (range) | 60 (2–98) | 64 (19–94) | 64 (19–93) |
Female sex (%) | 1430 (48.1) | 99 (39.8) | 49 (42.2) |
Median length of hospital stay in days (range) | 10 (1–366) | 31 (2–221) | 30 (2–209) |
Patient groups | |||
Surgery (%) | 1072 (36) | 142 (56.2) | 86 (74.1) |
Internal Medicine (%) | 883 (30) | 53 (21.3) | 17 (14.7) |
Onco-haematology (%) | 249 (8) | 39 (15.7) | 2 (1.7) |
Gynaecology & Obstetrics (%) | 456 (15) | 13 (5.2) | 9 (7.8) |
Ophthalmology, Dermatology, ENT, Radio & Nuclear (%) | 312 (10) | 4 (1.6) | 2 (1.7) |
Treatment/installations | |||
Antibiotic treatment (%) | 966 (32.5) | 233 (93.6) | 110 (94.8) |
Peripheral venous catheter (%) | 1325 (44.6) | 119 (47.8) | 57 (49.1) |
Central venous catheter (%) | 552 (18.6) | 126 (50.6) | 58 (50) |
Urinary catheter (%) | 590 (19.9) | 88 (35.3) | 42 (36.2) |
Intubation (%) | 136 (4.6) | 34 (13.7) | 17 (14.7) |
Immunosuppressed (%) | 330 (11.1) | 62 (24.9) | 19 (16.4) |
Surgery within the last 30Â days (%) | 1321 (44.4) | 151 (60.6) | 91 (78.4) |
Surgery with implant within the last year (%) | 440 (14.8) | 73 (29.3) | 47 (40.5) |